tert-Butyl (3-(azetidin-3-yl)-2,2-dimethylpropyl)carbamate hydrochloride

Catalog No.: 
ACWCYA005
CAS No.: 
2418711-42-7
Molecular Formula: 
C13H27ClN2O2
Molecular Weight: 
278.82
tert-Butyl (3-(azetidin-3-yl)-2,2-dimethylpropyl)carbamate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$455.00InquiryInquiry
100mg98%$672.00InquiryInquiry
250mg98%$924.00InquiryInquiry
1g98%$3659.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-(azetidin-3-yl)-2,2-dimethylpropyl)carbamate hydrochloride
IUPAC Nametert-butyl (3-(azetidin-3-yl)-2,2-dimethylpropyl)carbamate hydrochloride
Molecular FormulaC13H27ClN2O2
Molecular Weight278.82
SMILESO=C(OC(C)(C)C)NCC(C)(C)CC1CNC1.[H]Cl
InChI KeyPEMXAOZQDPKIMP-UHFFFAOYSA-N
Synonymtert-butyl N-[3-(azetidin-3-yl)-2,2-dimethylpropyl]carbamate hydrochloride;Tert-butyl N-[3-(azetidin-3-yl)-2,2-dimethylpropyl]carbamate
CAS No.2418711-42-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWCYA005 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWCYA005 route product structure diagram
    ACWCYA0052418711-42-7
Inquiry

2. ACWCYA005 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWCYA005 route product structure diagram
    ACWCYA0052418711-42-7
Inquiry

3. ACWCYA005 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWCYA005 route product structure diagram
    ACWCYA0052418711-42-7
Inquiry

Comments (0)